W.A. Stubbs

1.1k total citations
26 papers, 876 citations indexed

About

W.A. Stubbs is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, W.A. Stubbs has authored 26 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in W.A. Stubbs's work include Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). W.A. Stubbs is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). W.A. Stubbs collaborates with scholars based in United Kingdom, Tanzania and Canada. W.A. Stubbs's co-authors include David A. Pyke, Giuseppe Delitala, K. G. M. M. Alberti, G. M. Besser, A. E. Jones, Christopher R.W. Edwards, Sally J. Ratter, William Jeffcoate, Stephen R. Bloom and R. D. G. Leslie and has published in prestigious journals such as The Lancet, The Journal of Physiology and Diabetes.

In The Last Decade

W.A. Stubbs

25 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.A. Stubbs United Kingdom 17 329 307 281 186 124 26 876
Eckehart Wiedemann United States 16 117 0.4× 306 1.0× 212 0.8× 134 0.7× 113 0.9× 33 857
F. Massara Italy 17 105 0.3× 774 2.5× 138 0.5× 165 0.9× 79 0.6× 64 1.1k
P. J. A. MOULT United Kingdom 12 131 0.4× 248 0.8× 83 0.3× 49 0.3× 208 1.7× 21 645
L Devilla Italy 15 108 0.3× 308 1.0× 93 0.3× 60 0.3× 141 1.1× 43 590
Federico Mallo Spain 23 161 0.5× 651 2.1× 245 0.9× 293 1.6× 92 0.7× 50 1.3k
HL Fehm Germany 15 70 0.2× 363 1.2× 106 0.4× 138 0.7× 35 0.3× 51 756
Tadao Kakegawa Japan 9 662 2.0× 327 1.1× 150 0.5× 112 0.6× 45 0.4× 18 1.6k
Edward N. Ehrlich United States 19 45 0.1× 430 1.4× 222 0.8× 86 0.5× 83 0.7× 33 1.0k
H. G. Dörr Germany 15 54 0.2× 572 1.9× 215 0.8× 117 0.6× 28 0.2× 41 1.0k
Lucas C. González-Matías Spain 17 130 0.4× 389 1.3× 166 0.6× 194 1.0× 54 0.4× 21 860

Countries citing papers authored by W.A. Stubbs

Since Specialization
Citations

This map shows the geographic impact of W.A. Stubbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.A. Stubbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.A. Stubbs more than expected).

Fields of papers citing papers by W.A. Stubbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.A. Stubbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.A. Stubbs. The network helps show where W.A. Stubbs may publish in the future.

Co-authorship network of co-authors of W.A. Stubbs

This figure shows the co-authorship network connecting the top 25 collaborators of W.A. Stubbs. A scholar is included among the top collaborators of W.A. Stubbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.A. Stubbs. W.A. Stubbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feldberg, W., David A. Pyke, & W.A. Stubbs. (1985). ON THE ORIGIN OF NON-INSULIN-DEPENDENT DIABETES. The Lancet. 325(8440). 1263–1264. 14 indexed citations
2.
Feldberg, W., David A. Pyke, & W.A. Stubbs. (1985). Hyperglycaemia: Imitating Claude Bernard's Piqûre with drugs. Journal of the Autonomic Nervous System. 14(3). 213–228. 20 indexed citations
3.
Feldberg, W., David A. Pyke, & W.A. Stubbs. (1983). Hyperglycaemia, a morphine‐like effect produced by naloxone in the cat.. The Journal of Physiology. 340(1). 121–128. 14 indexed citations
4.
Stubbs, W.A., Giuseppe Delitala, G. M. Besser, et al.. (1983). THE ENDOCRINE AND METABOLIC EFFECTS OF CIMETIDINE. Clinical Endocrinology. 18(2). 167–178. 25 indexed citations
5.
Barnett, A H, David A. Pyke, W.A. Stubbs, et al.. (1983). Muscle Capillary Basement Membrane in Identical Twins Discordant for Insulin-dependent Diabetes. Diabetes. 32(6). 557–560. 20 indexed citations
6.
Stubbs, W.A., et al.. (1982). Insulin Clearance by Perfused Rat Lung. Hormone and Metabolic Research. 14(1). 8–9. 1 indexed citations
7.
Grossman, Ashley, W.A. Stubbs, R. Gaillard, et al.. (1981). STUDIES OF THE OPIATE CONTROL OF PROLACTIN, GH AND TSH. Clinical Endocrinology. 14(4). 381–386. 63 indexed citations
8.
Barnett, Anthony, et al.. (1981). Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics.. BMJ. 282(6277). 1656–1658. 68 indexed citations
9.
Stubbs, W.A., V.K. Bhargava, W. Feldberg, & David A. Pyke. (1980). Morphine hyper glycemia is abolished by anesthesia and unmasked by naloxone. Diabetologia. 19(6). 564. 2 indexed citations
10.
Datta, Harish K., et al.. (1980). Substrate Utilization by the Lung. Novartis Foundation symposium. 78. 85–104. 8 indexed citations
11.
Pyke, D A, et al.. (1980). MANAGEMENT OF THE PREGNANT DIABETIC: HOME OR HOSPITAL, WITH OR WITHOUT GLUCOSE METERS?. The Lancet. 315(8178). 1122–1124. 29 indexed citations
12.
Besser, G. M., Giuseppe Delitala, Ashley Grossman, W.A. Stubbs, & Tun Kuan Yeo. (1980). CHLORPROMAZINE, HALOPERIDOL, METOCLOPRAMIDE AND DOMPERIDONE RELEASE PROLACTIN THROUGH DOPAMINE ANTAGONISM AT LOW CONCENTRATIONS BUT PARADOXICALLY INHIBIT PROLACTIN RELEASE AT HIGH CONCENTRATIONS. British Journal of Pharmacology. 71(2). 569–573. 25 indexed citations
13.
Holgate, Stephen T., et al.. (1980). Airway and Metabolic Resistance to Intravenous Salbutamol: A Study in Normal Man. Clinical Science. 59(3). 155–161. 47 indexed citations
14.
Delitala, Giuseppe, et al.. (1979). EFFECTS OF THE H2 RECEPTOR ANTAGONIST CIMETIDINE ON PITUITARY HORMONES IN MAN. Clinical Endocrinology. 11(2). 161–167. 18 indexed citations
15.
Leslie, R. D. G., David A. Pyke, & W.A. Stubbs. (1979). SENSITIVITY TO ENKEPHALIN AS A CAUSE OF NON-INSULIN DEPENDENT DIABETES. The Lancet. 313(8112). 341–343. 91 indexed citations
16.
Delitala, Giuseppe, et al.. (1979). THE EFFECT OF LISURIDE HYDROGEN MALEATE, AN ERGOT DERIVATIVE ON ANTERIOR PITUITARY HORMONE SECRETION IN MAN. Clinical Endocrinology. 11(1). 1–9. 19 indexed citations
17.
Thomas, Dominique, et al.. (1977). Salbutamol-induced diabetic ketoacidosis.. BMJ. 2(6084). 438–438. 36 indexed citations
18.
Stubbs, W.A., et al.. (1977). THE EFFECT OF INSULIN ON LUNG METABOLISM IN THE RAT. Clinical Endocrinology. 7(3). 181–184. 17 indexed citations
19.
Opie, Lionel H. & W.A. Stubbs. (1976). 8Carbohydrate metabolism in cardiovascular disease. Clinics in Endocrinology and Metabolism. 5(3). 703–729. 18 indexed citations
20.
Woods, H. F., et al.. (1974). INHIBITION BY SALICYLATE OF GLUCONEOGENESIS IN THE ISOLATED PERFUSED RAT LIVER. Clinical and Experimental Pharmacology and Physiology. 1(6). 535–540. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026